Shares of Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as C$0.50 and last traded at C$0.50, with a volume of 1500 shares trading hands. The stock had previously closed at C$0.49.
Aptose Biosciences Stock Performance
The business’s 50-day moving average price is C$0.55 and its 200-day moving average price is C$1.07. The company has a debt-to-equity ratio of 670.80, a quick ratio of 5.41 and a current ratio of 0.80. The stock has a market cap of C$9.06 million, a P/E ratio of -0.08 and a beta of 1.36.
Aptose Biosciences (TSE:APS – Get Free Report) (NASDAQ:APTO) last issued its earnings results on Thursday, August 8th. The biotechnology company reported C($0.59) earnings per share for the quarter, topping the consensus estimate of C($0.80) by C$0.21. As a group, sell-side analysts expect that Aptose Biosciences Inc. will post -0.59 earnings per share for the current fiscal year.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
See Also
- Five stocks we like better than Aptose Biosciences
- How to Use the MarketBeat Dividend Calculator
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Using the MarketBeat Stock Split Calculator
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Technology Stocks Explained: Here’s What to Know About Tech
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
